Top

Published in:

17-07-2024 | Concise Research Report

Interest in Medication Deprescribing Among US Adults Aged 50–80

Authors: Sarah E. Vordenberg, PharmD, MPH, Matthias Kirch, MS, Dianne Singer, MPH, Erica Solway, PhD, MSW, MPH, J. Scott Roberts, PhD, Brian J. Zikmund-Fisher, PhD, Jeffrey T. Kullgren, MD, MS, MPH

Published in: Journal of General Internal Medicine | Issue 13/2024

Excerpt

The inappropriate or unnecessary use of medications is a growing public health problem which may be addressed via deprescribing, which is the supervised de-escalation or discontinuation of medications.^1,2 The objective of this study was to examine interest in medication deprescribing among U.S. adults aged 50–80 years. …

Medication Safety in Polypharmacy. Geneva: World Health Organization; 2019 (WHO/UHC/SDS/2019.11). Licence: CC BY-NC-SA 3.0 IGO. https://www.who.int/docs/default-source/patient-safety/who-uhc-sds-2019-11-eng.pdf.

Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827-834. https://doi.org/10.1001/jamainternmed.2015.0324CrossRefPubMed

Technical overview of the Amerispeak ® panel Norc’s probability-based household panel. AmeriSpeak. Retrieved from https://amerispeak.norc.org/content/dam/amerispeak/research/pdf/AmeriSpeak%20Technical%20Overview%202019%2002%2018.pdf. Accessed 4 May 2024.

Reeve E, Low LF, Shakib S, Hilmer SN. Development and validation of the revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016;33(12):913-928. https://doi.org/10.1007/s40266-016-0410-1CrossRefPubMed

Vordenberg SE, Weir KR, Jansen J, Todd A, Schoenborn N, Scherer AM. Harm and medication-type impact agreement with hypothetical deprescribing recommendations: A vignette-based experiment with older adults across four countries. J Gen Intern Med. 2023;38(6):1439-1448. https://doi.org/10.1007/s11606-022-07850-5.CrossRefPubMed

Jiang V, Brooks EM, Tong ST, Heintzman J, Krist AH. Factors influencing uptake of changes to clinical preventive guidelines. J Am Board Fam Med. 2020;33(2):271-278. https://doi.org/10.3122/jabfm.2020.02.190146.CrossRefPubMedPubMedCentral

Coe AB, Farris KB, Solway E, et al. Predictors of receipt of comprehensive medication reviews in older adults. J Gerontol A Biol Sci Med Sci. 2023;78(3):463-469. https://doi.org/10.1093/gerona/glac096CrossRefPubMed

Title: Interest in Medication Deprescribing Among US Adults Aged 50–80
Authors: Sarah E. Vordenberg, PharmD, MPH
Matthias Kirch, MS
Dianne Singer, MPH
Erica Solway, PhD, MSW, MPH
J. Scott Roberts, PhD
Brian J. Zikmund-Fisher, PhD
Jeffrey T. Kullgren, MD, MS, MPH
Publication date: 17-07-2024
Publisher: Springer International Publishing
Published in: Journal of General Internal Medicine / Issue 13/2024
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-024-08945-x

Advance Care Planning (ACP) in Medicare Beneficiaries with Heart Failure

Open Access
Heart Failure
Original Research

Effectiveness of a Multifaceted Implementation Strategy to Increase Equitable Hospital at Home Utilization: An Interrupted Time Series Analysis

Original Research

Good Neighbors: The Pivotal Role of a Career Ally

Healing Arts

The Discharge “Home” That Haunts Me to This Day

Lice
Healing Arts

Reimagining How We Synthesize Information to Impact Clinical Care, Policy, and Research Priorities in Real Time: Examples and Lessons Learned from COVID-19

COVID-19
Perspective

Binge Eating and Weight Loss Behaviors in Low-Income Adults at Risk for Food Insecurity

Binge Eating Disorder
Concise Research Report

Women’s health knowledge hub

Menopause
Clinical Collection

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Live
Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital

Prof. Ronald F. van Vollenhoven

Developed by: Springer Medicine

Keynote series | Spotlight on managing health in obesity

Springer Medicine

Interest in Medication Deprescribing Among US Adults Aged 50–80

Excerpt

Other articles of this Issue 13/2024

Advance Care Planning (ACP) in Medicare Beneficiaries with Heart Failure

Effectiveness of a Multifaceted Implementation Strategy to Increase Equitable Hospital at Home Utilization: An Interrupted Time Series Analysis

Good Neighbors: The Pivotal Role of a Career Ally

The Discharge “Home” That Haunts Me to This Day

Reimagining How We Synthesize Information to Impact Clinical Care, Policy, and Research Priorities in Real Time: Examples and Lessons Learned from COVID-19

Binge Eating and Weight Loss Behaviors in Low-Income Adults at Risk for Food Insecurity

Women’s health knowledge hub

Keynote webinar | Spotlight on advances in lupus

Keynote series | Spotlight on managing health in obesity

Springer Medicine

Excerpt

Please log in to get access to this content